Literature DB >> 7676269

Pyrexia of unknown origin--approach to management.

S Y Wong1, M S Lam.   

Abstract

Pyrexia of unknown origin (PUO) remains one of the major diagnostic challenges for the clinician. Although infection, malignancy and collagen vascular disease remain the 3 most important causes of PUO, the relative importance of different disease entities within each of these major categories has changed because of improvements in serodiagnosis, culture techniques and radiologic imaging modalities. A detailed clinical history and meticulous physical examination remain the mainstay of the approach to management of patients with PUO. There is no set of "routine" investigations that patients with PUO should be subjected to. Instead, diagnostic testing should be individualised and guided by abnormalities found on clinical examination and simple laboratory testing. In patients in whom the diagnosis remains obscure in spite of extensive investigations and in whom the disease process is clearly progressive, judicious use of narrow spectrum anti-microbial therapy may be warranted. In the majority of the other patients who remain stable, careful clinical observation for new symptoms and signs are advised in the place of multiple courses of antimicrobials.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676269

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states.

Authors:  M Jaruskova; O Belohlavek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-30       Impact factor: 9.236

2.  Fatal methotrexate toxicity: could it have been avoided?

Authors:  Reva Tripathi; Preeta Kaur Chugh; Deepa Kaur Chugh; Vertika Verma; Y M Mala
Journal:  BMJ Case Rep       Date:  2013-06-12

3.  Fever of Unknown Origin in Children: A 6 year- Experience in a Tertiary Pediatric Egyptian Hospital.

Authors:  Rasha H Hassan; Ashraf E Fouda; Shaimaa M Kandil
Journal:  Int J Health Sci (Qassim)       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.